John P. Schmid, Director at Xeris Biopharma Holdings, Inc. (XERS), bought 4,515 shares at $2.25 ($10K) on 2024-08-12, disclosed to the SEC on 2024-08-13.
Open-market purchase of $10k XERS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| XERS | BUY | 2024-05-10 | $10K | — | Filing → |
| DSGN | BUY | 2024-03-25 | $166K | — | Filing → |